Literature DB >> 8860427

Fat emulsions based on structured lipids (1,3-specific triglycerides): an investigation of the in vivo fate.

H Hedeman1, H Brøndsted, A Müllertz, S Frokjaer.   

Abstract

PURPOSE: Structured lipids (1,3-specific triglycerides) are new chemical entities made by enzymatic transesterification of the fatty acids in the 1,3 positions of the triglyceride. The purpose of this study is to characterize structured lipids with either short chain fatty acids or medium chain fatty acids in the 1,3 positions with regard to their hydrophobicity, and investigate the in vivo fate in order to evaluate the potential of structured lipids as core material in fat emulsions used as parenteral drug delivery system.
METHODS: The lipids were characterized by employing reversed phase high performance liquid chromatography. The biodistribution of radioactively labeled emulsions was studied in rats.
RESULTS: By employing high performance liquid chromatography a rank order of the hydrophobicities of the lipids could be given, with the triglycerides containing long chain fatty acids being the most hydrophobic and the structured lipid with short chain fatty acids in the 1,3 positions the least. When formulated as fat emulsions, the emulsion based on structured lipids with short fatty acids in the 1,3 positions was removed slower from the general blood circulation compared to emulsions based on lipids with long chain fatty acids in the 1,3 positions.
CONCLUSIONS: The type of core material influences the in vivo circulation time of fat emulsions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8860427     DOI: 10.1023/a:1016095415849

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Studies on an intravenous fat tolerance test. Methodological, experimental and clinical experiences with Intralipid.

Authors:  S Rössner
Journal:  Acta Med Scand Suppl       Date:  1974

Review 2.  Lipid emulsions as drug delivery systems.

Authors:  S S Davis; C Washington; P West; L Illum; G Liversidge; L Sternson; R Kirsh
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 3.  Polymeric microspheres as drug carriers.

Authors:  S S Davis; L Illum
Journal:  Biomaterials       Date:  1988-01       Impact factor: 12.479

4.  Liposomes for the sustained drug release in vivo.

Authors:  G Blume; G Cevc
Journal:  Biochim Biophys Acta       Date:  1990-11-02

Review 5.  Lipid microspheres for drug delivery from the pharmaceutical viewpoint.

Authors:  T Yamaguchi; Y Mizushima
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1994       Impact factor: 4.889

Review 6.  Lipoprotein lipase: its physiological and clinical significance.

Authors:  M Hamosh; P Hamosh
Journal:  Mol Aspects Med       Date:  1983

7.  Fat emulsion particle size: influence on the clearance rate and the tissue lipolytic activity.

Authors:  O Lutz; Z Meraihi; J L Mura; A Frey; G H Riess; A C Bach
Journal:  Am J Clin Nutr       Date:  1989-12       Impact factor: 7.045

8.  Activities of lipoprotein lipase and hepatic lipase on long- and medium-chain triglyceride emulsions used in parenteral nutrition.

Authors:  O Lutz; T Lave; A Frey; Z Meraihi; A C Bach
Journal:  Metabolism       Date:  1989-06       Impact factor: 8.694

9.  Metabolism of emulsions containing medium- and long-chain triglycerides or interesterified triglycerides.

Authors:  M Hultin; A Müllertz; M A Zundel; G Olivecrona; T T Hansen; R J Deckelbaum; Y A Carpentier; T Olivecrona
Journal:  J Lipid Res       Date:  1994-10       Impact factor: 5.922

10.  Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action.

Authors:  R J Deckelbaum; J A Hamilton; A Moser; G Bengtsson-Olivecrona; E Butbul; Y A Carpentier; A Gutman; T Olivecrona
Journal:  Biochemistry       Date:  1990-02-06       Impact factor: 3.162

  10 in total
  1 in total

1.  Protein Adsorption Patterns and Analysis on IV Nanoemulsions-The Key Factor Determining the Organ Distribution.

Authors:  Cornelia M Keck; Mirko Jansch; Rainer H Müller
Journal:  Pharmaceutics       Date:  2012-12-21       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.